文献速递肾癌与肾肿瘤

复杂肿瘤或相关合并症患者行部分肾切除术时机器人辅助手术是否禁忌?发病情况、肾功能与肿瘤学结局的对比分析

Is Robot-assisted Surgery Contraindicated in the Case of Partial Nephrectomy for Complex Tumours or Relevant Comorbidities? A Comparative Analysis of Morbidity, Renal Function, and Oncologic Outcomes.
PubMed 文献 · Eur Urol Oncol · 2018-05-15

该观察性研究纳入472例cT1-2cN0cM0肾肿块患者,比较机器人辅助部分肾切除术(RAPN)与开放部分肾切除术(OPN)。经倾向性评分匹配后,RAPN与更低的总体并发症(21% vs 36%)和主要并发症(3% vs 9%)相关,且在高PADUA评分、高CCI、大肿瘤和低术前eGFR患者中该获益一致;两组热缺血时间、术后及1年eGFR、切缘阳性率及5年肿瘤学结局均无显著差异。

要点

  • RAPN较OPN总体并发症更低(21% vs 36%),主要并发症更低(3% vs 9%)。
  • 高PADUA评分、高CCI、大肿瘤及低术前eGFR患者中RAPN的并发症获益一致。
  • 两组热缺血时间、肾功能、切缘阳性率及5年肿瘤学结局均无显著差异。

核心结论

  • RAPN与更好的围手术期发病情况和更低的并发症率相关,无论肿瘤复杂性和患者合并症状态如何。
  • RAPN与OPN的功能和肿瘤学结局相当。

研究设计与样本

  • 观察性研究,纳入472例诊断为cT1-2cN0cM0肾肿块并接受RAPN或OPN治疗的患者,数据来自两个前瞻性机构数据库。
  • 采用倾向性评分匹配校正基线混杂因素,匹配变量包括诊断时年龄、性别、Charlson合并症指数、术前eGFR、单肾状态、肿瘤大小和侧别、总PADUA评分、各PADUA评分条目及手术年份。
  • 使用线性回归和逻辑回归估计手术方式对连续变量和分类结局的效应,并用交互检验进行亚组分析。

主要发现

  • RAPN组总体并发症发生率21% vs OPN组36%(p<0.0001),主要并发症发生率3% vs 9%(p=0.03)。
  • 高PADUA评分、高CCI、大肿瘤和低术前eGFR患者中RAPN的并发症获益一致(交互检验均p>0.05)。
  • 两组热缺血时间、术后和1年eGFR、切缘阳性率均无显著差异(均p>0.05)。
  • 中位随访41个月,两组5年局部无复发生存率、无系统性进展生存率和无病生存率均无显著差异(均p>0.05)。

临床怎么用

  • 原文结论认为RAPN与更好的围手术期发病情况和更低的并发症率相关,无论肿瘤复杂性和患者合并症状态如何。
  • 原文结论认为RAPN与OPN的功能和肿瘤学结局相当。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Available comparisons between open partial nephrectomy (OPN) and robot-assisted partial nephrectomy (RAPN) are scarce, incomplete, and affected by non-negligible risk of bias. OBJECTIVE: To compare RAPN and OPN. DESIGN, SETTING, AND PARTICIPANTS: This was an observational study of 472 patients diagnosed with a cT1-2cN0cM0 renal mass and treated with RAPN or OPN assessed in two prospective institutional databases. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The study outcomes were morbidity, complications, warm ischaemia time, renal function, positive surgical margins, and oncologic outcomes. Propensity score matching for age at diagnosis, gender, Charlson comorbidity index, preoperative estimated glomerular filtration rate (eGFR), single kidney status, tumour size and side, total PADUA score, any individual PADUA score item, and year of surgery was used to account for baseline confounders. The effect of surgical approach was estimated using linear and logistic regressions for continuous and categorical outcomes. An interaction test was used for subgroup analyses. RESULTS AND LIMITATIONS: Relative to OPN, RAPN was associated with lower rates for overall (21% vs 36%; p<0.0001) and major (3% vs 9%; p=0.03) complications. This benefit was consistent in patients with high PADUA scores, high CCI, large tumours, and low preoperative eGFR (all p>0.05, interaction test). No difference between the groups was observed for warm ischaemia time, postoperative and 1-yr eGFR, and positive surgical margins (all p>0.05). After median follow-up of 41 mo, there was no difference between the groups for the 5-yr rates of local recurrence-free, systemic progression-free, and disease-free survival (all p>0.05). CONCLUSIONS: RAPN is associated with overall better perioperative morbidity and lower rates of complications, regardless of characteristics such as tumour complexity and patient comorbidity status. Functional and oncologic outcomes are equal after RARP and OPN. PATIENT SUMMARY: Robot-assisted partial nephrectomy is associated with a better morbidity profile than open partial nephrectomy (OPN) and provides the same cancer control and renal function preservation observed after OPN.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Larcher A, Capitanio U, De Naeyer G, et al. Is Robot-assisted Surgery Contraindicated in the Case of Partial Nephrectomy for Complex Tumours or Relevant Comorbidities? A Comparative Analysis of Morbidity, Renal Function, and Oncologic Outcomes. Eur Urol Oncol. 2018. PMID: 31100229. doi:10.1016/j.euo.2018.01.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。